CONGENITAL ADRENAL HYPERPLASIA
Clinical trials for CONGENITAL ADRENAL HYPERPLASIA explained in plain language.
Never miss a new study
Get alerted when new CONGENITAL ADRENAL HYPERPLASIA trials appear
Sign up with your email to follow new studies for CONGENITAL ADRENAL HYPERPLASIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to help kids with rare hormone disorder use less steroids
Disease control Recruiting nowThis study is testing an investigational drug called atumelnant in children aged 1 to 18 with a genetic hormone disorder called congenital adrenal hyperplasia (CAH). The main goals are to see if the drug is safe, if it can help control abnormal hormone levels, and if it allows ch…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE2, PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New drug tested for rare hormone disorder
Disease control Recruiting nowThis early-stage trial is testing a new drug called Lu AG13909 in adults with congenital adrenal hyperplasia (CAH), a rare genetic condition that affects hormone production. The main goals are to check the drug's safety, see how it moves through the body, and measure its effect o…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE1, PHASE2 • Sponsor: H. Lundbeck A/S • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
New hope for tiniest patients with rare hormone disorder
Disease control Recruiting nowThis study is testing a drug called crinecerfont in babies under 2 years old who have congenital adrenal hyperplasia (CAH), a rare genetic hormone condition. The main goal is to see how the baby's body processes the drug and to check if it is safe and well-tolerated. It is a smal…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE2 • Sponsor: Neurocrine Biosciences • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New pill could help control rare hormone disorder, reduce steroid dependence
Disease control Recruiting nowThis study is testing whether a daily pill called atumelnant can better control hormone levels in adults with classic congenital adrenal hyperplasia (CAH), a rare genetic condition. About 150 participants will receive either atumelnant or a placebo pill for comparison. The main g…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE3 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Daily pill trial aims to tame hormone disorder, boost health
Disease control Recruiting nowThis study is comparing a new once-daily pill against standard treatments for adults with congenital adrenal hyperplasia (CAH), a lifelong hormone condition. It aims to see if the new pill, designed to mimic the body's natural cortisol rhythm, can better control the disease and r…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE4 • Sponsor: Federico II University • Aim: Disease control
Last updated Mar 18, 2026 18:25 UTC
-
Extended trial tests new drug for rare hormone disorder
Disease control Recruiting nowThis study aims to learn about the long-term safety and effectiveness of the experimental drug atumelnant (CRN04894) for people with congenital adrenal hyperplasia (CAH), a rare genetic hormone condition. It is open to about 150 people who have already taken this drug in a previo…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Phase: PHASE2 • Sponsor: Crinetics Pharmaceuticals Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:23 UTC
-
Hospital launches major effort to map the mysteries of rare diseases
Knowledge-focused Recruiting nowThis study aims to create a single, large registry to collect information on many different rare diseases. It will enroll about 380 patients already being treated at the Hospital Italiano de Buenos Aires who have one of the listed rare conditions. The goal is to gather data to be…
Matched conditions: CONGENITAL ADRENAL HYPERPLASIA
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated Mar 10, 2026 12:53 UTC